A Phase 1/2 interventional study of interview and advising and 3 follow up interviews and personal advising in Hip Arthroplasty, sponsored by University of Aarhus. Completed at 6 sites in Denmark. Open to participants aged 65 Years to 95 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-29.
Sponsored by University of Aarhus · Phase 1/2, Interventional, and Other
Patients over 65 years do not have a self care ability the surgery benefits them.
The aim of this study is development of a rehabilitation program based on patients' self-rated health.
Fase 1: 600 patients waiting for or already having received total hip-/knee-replacement participated in a questionnaire study using SF- 36. The aim was to document self-rated health among this population.
Fase 2: Results from the cross section study form the base for the RCT, where 160 patients over 65 years undergoing THR, 80 patients are in an intervention group and 80 patients in a control group. A nurse intervention program is tested, and results from the study will form the base for a structured rehabilitation program.
University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:patients over 65 years undergoing total hip replacement
-
Exclusion Criteria:
Selfrated health among the population shows significant dysfunction among patients over 75 years, patient living alone and patients depended on help from others
undergoing
we know next year
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Aarhus